Skip to main content
logo
Obsidian Therapeutics, Inc. (OBX)
NASDAQ: OBX · Real-Time Price · USD
16.82
-0.27 (-1.58%)
Sep 4, 2026, 4:00 PM EDT - Market closed

Obsidian Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Jun '26 Dec '25 Dec '24
Cash & Equivalents
17.9840.4149.76
Short-Term Investments
16.4640.08118.51
Cash & Short-Term Investments
34.4580.49168.27
Cash Growth
--52.17%-
Prepaid Expenses
11.911.034.58
Total Current Assets
46.3681.52172.85
Property, Plant & Equipment
4.086.069.86
Other Long-Term Assets
111
Total Assets
51.4488.58183.71

Liabilities

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Jun '26 Dec '25 Dec '24
Accounts Payable
0.370.011.82
Accrued Expenses
15.6510.8810.3
Current Portion of Leases
1.983.062.99
Other Current Liabilities
2.21.420.98
Total Current Liabilities
20.215.3616.09
Long-Term Leases
0.931.223.82
Other Long-Term Liabilities
000.21
Total Liabilities
21.1316.5920.12

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Jun '26 Dec '25 Dec '24
Common Stock
000
Additional Paid-In Capital
41.7229.8720.92
Retained Earnings
-341.43-295.94-195.33
Comprehensive Income & Other
-00.02-0.03
Total Common Equity
-299.71-266.04-174.43
Shareholders' Equity
30.3271.99163.6
Total Liabilities & Equity
51.4488.58183.71

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Jun '26 Dec '25 Dec '24
Total Debt
2.914.286.81
Net Cash (Debt)
31.5476.2161.46
Net Cash Growth
--52.80%-
Net Cash Per Share
1.421557.42-
Filing Date Shares Outstanding
61.7713.94-
Total Common Shares Outstanding
22.1913.94-
Working Capital
26.1666.15156.76
Book Value Per Share
-13.51-19.08-
Tangible Book Value
-299.71-266.04-174.43
Tangible Book Value Per Share
-13.51-19.08-
Machinery
-10.7810.7
Leasehold Improvements
-0.260.26
SEC Filings: 10-K · 10-Q